EcoDrugPlus

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSMMMG00000003719
Gene Symbol: AVPR1B
3 Cross references
134 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSMMMG00000008488
Gene Symbol: AVPR2
3 Cross references
231 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSMMMG00000015102
Gene Symbol: AHR
3 Cross references
154 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSMMMG00000008526
Gene Symbol: AURKA
3 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSMMMG00000020278
Gene Symbol: AURKB
3 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSMMMG00000000269
Gene Symbol: AURKC
1 Cross references
96 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSMMMG00000022841
Gene Symbol: BACE1
3 Cross references
217 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSMMMG00000001738
Gene Symbol: BDKRB1
1 Cross references
147 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSMMMG00000001726
Gene Symbol: BDKRB2
3 Cross references
356 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSMMMG00000007862
Gene Symbol: BCHE
3 Cross references
130 Possible Orthologues:

Camp-Dependent Protein Kinase Catalytic Subunit Beta

Ensembl ID : ENSMMMG00000012977
Gene Symbol: LOC107135580
2 Cross references
228 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4c-Like

Ensembl ID : ENSMMMG00000001654
Gene Symbol: LOC107135112
2 Cross references
267 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).